Research Library

 
Your search returned 786 results
Product

Tobacco Pricing Strategy Laws

Tobacco use remains a leading cause of preventable death in the United States, known to cause cancer and other harmful health conditions, including, but not limited to, respiratory and cardiovascular disease. Implementing evidence-based policies that reduce smoking and tobacco consumption can decrease tobacco-related illnesses and death. One of the most effective strategies to decrease tobacco use is to raise the price of tobacco products, something which state governments can accomplish by establishing specific taxes and pricing limits for tobacco products.

Product Type: 
 
 
Product

Toward Healthy Drug Policy in the United States — The Case of Safehouse

A new Perspective article in the New England Journal of Medicine examines a recent decision by a Philadelphia judge to reject the argument that an overdose prevention site, called Safehouse, would violate the Controlled Substances Act.

The decision signals a move toward an approach to regulating drugs that minimizes both the harms of drugs and the harms caused by regulation itself – worthy goals all around, the authors write.

Product Type: 
 
 
Product
 
 
Product
 
Product
 
Product

Selective Breath Testing Sobriety Checkpoints

The Problem: The operation of motor vehicles while intoxicated is a major public health problem. In 2016, roughtly 10,500 people died in motor vehicle crashes involving an alcohol-impaired driver, accounting for nearly 1/3 of all traffic related deaths. CDC: Impaired Driving Factsheet. Approximately 6,500 (62%) of these individuals had a Blood Alcohol Content (BAC) level of 0.08 g/dL or higher. The remaining fatalities consisted of passengers (29%( and non-passengers (9%).

 
Product

Laws and Policies Requiring Specified Vaccinations among High Risk Populations

The Problem: Vaccine coverage for vaccine preventable disease is an essential public health goal. Vaccination against specific diseases is particularly important for high risk populations, which may include individuals of a certain age (e.g., greater than 68 years for Pneumococcal Polysaccharide) or with specified medical conditions (e.g., HIV/AIDS for influenza). CDC: General Recommendations on Immunization.

 

Pages